original ) (raw )Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet
Karl-Christian Bergmann
Allergo Journal International
View PDFchevron_right
Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial
Piotr Kuna
JAMA, 2016
View PDFchevron_right
SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms
Christian Ljørring
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2015
View PDFchevron_right
House-Dust Mite Immunotherapy in Asthma: Uncertainties and Therapeutic Strategies
Mei Fong Liew
Current Treatment Options in Allergy, 2019
View PDFchevron_right
Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy
Franco Frati , Cristoforo Incorvaia
Drug Design, Development and Therapy, 2012
View PDFchevron_right
Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study
margitta worm
Allergy, 2006
View PDFchevron_right
Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy
Santiago Martín
Journal of Allergy and Clinical Immunology, 2011
View PDFchevron_right
House dust mite allergens in asthma and allergy
Wendy-anne Smith
Trends in Molecular Medicine, 2010
View PDFchevron_right
House Dust Mite Immunotherapy in Iraqi Patients with Allergic Rhinitis and Asthma
amar mohamed
Pharmacotherapy, 2012
View PDFchevron_right
Allergic rhinitis: the eligible candidate to mite immunotherapy in the real world
Cristoforo Incorvaia
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2017
View PDFchevron_right
Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity
Werner Pichler
Allergy, 2001
View PDFchevron_right
Respiratory allergy caused by house dust mites: What do we really know
Nancy Krone
View PDFchevron_right
Use of ultramolecular potencies of allergen to treat asthmatic people allergic to house dust mite: double blind randomised controlled clinical trial
Gina Dolan
BMJ, 2002
View PDFchevron_right
A Three-Year Course of House Dust Mite Sublingual Immunotherapy Appears Effective in Controlling the Symptoms of Allergic Rhinitis
Teodora Dimcheva
American Journal of Rhinology & Allergy, 2018
View PDFchevron_right
Efficacy and safety of SQ house dust mite (HDM) SLIT-tablet treatment of HDM allergic asthma
Christian Ljørring
Expert Review of Clinical Immunology, 2016
View PDFchevron_right
Severity and disease control before house dust mite immunotherapy initiation: ANTARES a French observational survey
Pascal Demoly
Allergy, Asthma & Clinical Immunology, 2016
View PDFchevron_right
Selection of house dust mite–allergic patients by molecular diagnosis may enhance success of specific immunotherapy
carmen bunu
The Journal of Allergy and Clinical Immunology, 2019
View PDFchevron_right
Evaluation of household dust mite exposure and levels of specific IgE and IgG antibodies in asthmatic patients enrolled in a trial of immunotherapy
Manuel Lopez
Journal of Allergy and Clinical Immunology, 1996
View PDFchevron_right
Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite
Y. Sertdemir
Journal of investigational allergology & clinical immunology, 2007
View PDFchevron_right
Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial
Christian Ljørring
Journal of Allergy and Clinical Immunology, 2014
View PDFchevron_right
Evaluation of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy
Muge Toyran
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand, 2010
View PDFchevron_right
Clinical and laboratory profiles of pediatric asthma patients with house dust mite (HDM)–specific subcutaneous immunotherapy: A single center, cross sectional study
Desy Wulandari
Pediatrics Sciences Journal, 2022
View PDFchevron_right
Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice
Víctor Alva Alva
Allergologia Et Immunopathologia, 2011
View PDFchevron_right
Allergy to House Dust Mites and Asthma
Evelyn I . Milian
Puerto Rico Health Sciences Journal, 2004
View PDFchevron_right
Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial
Tunc Akkoc
Clinical & Experimental Allergy, 2010
View PDFchevron_right
House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis
Shigeharu Fujieda
Allergy, 2016
View PDFchevron_right
REVIEW ARTICLE Allergy to House Dust Mites and Asthma
Evelyn I . Milian
View PDFchevron_right
Exposure to house dust mite allergens and the clinical activity of asthma
Adnan Custovic
Journal of Allergy and Clinical Immunology, 1996
View PDFchevron_right
Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period
Prof. Dr. Mine Ergüven
Journal of investigational allergology & clinical immunology: official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología
View PDFchevron_right
Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study
T. Bieber
Clinical & Experimental Allergy, 2007
View PDFchevron_right
The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA²LEN meta-analysis
fatih oghan
Allergy, 2009
View PDFchevron_right